Navigating the future of lab developed tests – what’s next for diagnostics?

Looking to better understand the future trajectory of laboratory developed tests (LDTs)? In this white paper we delve into the critical aspects of laboratory developed tests and the regulatory landscape that governs them. As laboratory developed tests continue to play a pivotal role in advancing diagnostic capabilities, it is essential for laboratories to stay compliant with evolving regulations while embracing innovative technologies. Our white paper sheds light on best practices for achieving compliance, the importance of quality management systems (QMS) and the future trends shaping the industry.

Key highlights covered in the whitepaper include:

• In-depth analysis of LDT regulations: Get a thorough understanding of critical guidelines and standards set by governing bodies, including the FDA's final rule and ISO 13485 compliance.

• Technological advancements in diagnostics: Explore how innovations in diagnostics are transforming patient care through precision medicine, early detection, non-invasive testing and disease monitoring.

• The importance of quality management systems: Learn how robust QMS ensures the safety, efficacy and reliability of laboratory developed tests.

• Ideagen’s solutions for LDT compliance: Discover how Ideagen’s quality solutions can streamline compliance processes, enhance traceability and support continuous improvement.